Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,916 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
Kinugawa K, Nagai R, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T, Hori M; J-Land Investigators. Kinugawa K, et al. Among authors: sakamoto a. Adv Ther. 2014 Apr;31(4):426-39. doi: 10.1007/s12325-014-0111-2. Epub 2014 Mar 19. Adv Ther. 2014. PMID: 24643403 Free PMC article. Clinical Trial.
Clinical role and efficacy of landiolol in the intensive care unit.
Yoshida Y, Terajima K, Sato C, Akada S, Miyagi Y, Hongo T, Takeda S, Tanaka K, Sakamoto A. Yoshida Y, et al. Among authors: sakamoto a. J Anesth. 2008;22(1):64-9. doi: 10.1007/s00540-007-0573-3. Epub 2008 Feb 27. J Anesth. 2008. PMID: 18306018
Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).
Sakamoto A, Kitakaze M, Takamoto S, Namiki A, Kasanuki H, Hosoda S; JL-KNIGHT study group. Sakamoto A, et al. Circ J. 2012;76(5):1097-101. doi: 10.1253/circj.cj-11-1332. Epub 2012 Feb 23. Circ J. 2012. PMID: 22361918 Free article. Clinical Trial.
Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T, Hori M; J-Land Investigators. Nagai R, et al. Among authors: sakamoto a. Circ J. 2013;77(4):908-16. doi: 10.1253/circj.cj-12-1618. Epub 2013 Mar 15. Circ J. 2013. PMID: 23502991 Free article. Clinical Trial.
Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias　- Outcomes of J-Land II Study.
Ikeda T, Shiga T, Shimizu W, Kinugawa K, Sakamoto A, Nagai R, Daimon T, Oki K, Okamoto H, Yamashita T; J-Land II Study Investigators. Ikeda T, et al. Among authors: sakamoto a. Circ J. 2019 Jun 25;83(7):1456-1462. doi: 10.1253/circj.CJ-18-1361. Epub 2019 May 23. Circ J. 2019. PMID: 31118364 Free article. Clinical Trial.
1,916 results